BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33687063)

  • 1. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
    Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
    J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer.
    Wallner LP; Reyes-Gastelum D; Hamilton AS; Ward KC; Hawley ST; Haymart MR
    J Clin Oncol; 2019 Aug; 37(24):2152-2161. PubMed ID: 31283406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that influence radioactive iodine use for thyroid cancer.
    Papaleontiou M; Banerjee M; Yang D; Sisson JC; Koenig RJ; Haymart MR
    Thyroid; 2013 Feb; 23(2):219-24. PubMed ID: 23134514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
    Moten AS; Zhao H; Intenzo CM; Willis AI
    Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Too Much of a Good Thing: Radioactive Iodine Ablation Use for Micropapillary Thyroid Carcinoma.
    Chae AW; Martinez SR
    Am Surg; 2018 May; 84(5):637-643. PubMed ID: 29966562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overuse of radioactive iodine in low-risk papillary thyroid cancer patients.
    Moten AS; Zhao H; Willis AI
    Surg Oncol; 2019 Jun; 29():184-189. PubMed ID: 31196486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
    Molenaar RJ; Sidana S; Radivoyevitch T; Advani AS; Gerds AT; Carraway HE; Angelini D; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Maciejewski JP; Majhail NS; Sekeres MA; Mukherjee S
    J Clin Oncol; 2018 Jun; 36(18):1831-1839. PubMed ID: 29252123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
    Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
    Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioactive iodine in differentiated thyroid cancer: a national database perspective.
    Orosco RK; Hussain T; Noel JE; Chang DC; Dosiou C; Mittra E; Divi V; Orloff LA
    Endocr Relat Cancer; 2019 Oct; 26(10):795-802. PubMed ID: 31443087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
    Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
    Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
    Papaleontiou M; Chen DW; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Haymart MR
    Thyroid; 2021 Sep; 31(9):1383-1390. PubMed ID: 33779292
    [No Abstract]   [Full Text] [Related]  

  • 14. Disease severity and radioactive iodine use for thyroid cancer.
    Haymart MR; Muenz DG; Stewart AK; Griggs JJ; Banerjee M
    J Clin Endocrinol Metab; 2013 Feb; 98(2):678-86. PubMed ID: 23322816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
    Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
    Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant radioactive iodine use among differentiated thyroid cancer patients in the military health system.
    Gill AA; Enewold L; Zahm SH; Shriver CD; Zheng L; McGlynn KA; Zhu K
    Mil Med; 2014 Sep; 179(9):1043-50. PubMed ID: 25181724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.
    Iizuka Y; Katagiri T; Ogura K; Mizowaki T
    Ann Nucl Med; 2019 Jul; 33(7):495-501. PubMed ID: 30955202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.